Johnson & Johnson Completes Divestiture of LifeScan to Platinum Equity

Tuesday, October 2, 2018 Diabetes News
Email Print This Page Comment bookmark
Font : A-A+

NEW BRUNSWICK, New Jersey, Oct. 2, 2018 /PRNewswire/ --áJohnson & Johnson (NYSE: JNJ) today announced that it has completed

the divestiture of its LifeScan business to Platinum Equity for approximately $2.1 billion.

LifeScan, Inc. is a world leader in blood glucose monitoring and maker of the OneTouch« brand of products. It

generated net revenues of approximately $1.5 billion in 2017.

The Johnson & Johnson Family of Companies will continue to serve those impacted by diabetes through innovative products, services and solutions from its Medical Device, Pharmaceuticals and Consumer businesses. This includes important leadership and innovation in areas such as bariatric surgery and through medicines such as INVOKANA« (canagliflozin) and INVOKAMET« (canagliflozin/metformin HCl).

Johnson & Johnson will discuss this transaction during its scheduled quarterly earnings call on October 16, 2018.

About Johnson & Johnson At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That's why for more than 130 years, we have aimed to keep people well at every age and every stage of life. Today, as the world's largest and most broadly-based health care company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere. We are blending our heart, science and ingenuity to profoundly change the trajectory of health for humanity.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store